CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,516 | +30.3% | 17,875 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $204,601 | +54.9% | 18,685 | +23.3% | 0.00% | 0.0% |
| Q1 2023 | $132,099 | +408.1% | 15,149 | +168.8% | 0.00% | – |
| Q1 2021 | $26,000 | -18.8% | 5,635 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +433.3% | 5,635 | +40.3% | 0.00% | – |
| Q1 2020 | $6,000 | -25.0% | 4,015 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | -61.9% | 4,015 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | -27.6% | 4,015 | 0.0% | 0.00% | – |
| Q2 2019 | $29,000 | -45.3% | 4,015 | 0.0% | 0.00% | – |
| Q1 2019 | $53,000 | +26.2% | 4,015 | -24.6% | 0.00% | – |
| Q4 2018 | $42,000 | -28.8% | 5,327 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $59,000 | -16.9% | 5,327 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $71,000 | – | 5,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |